Decipher Labs Ltd
16 Nov 2026 12:00 AM
Decipher Labs Ltd consolidated sales up 27.39% on year in Q2FY2027, net profit surged by 542.47%,
Decipher Labs Ltd`s net loss stood at Rs 14.07 crore in Q2FY2027 compared to a net profit of Rs 0.02 crore in Q2FY26. The revenue from operations gained significantly 27.39% to Rs 3.07 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.76 lakh crore, easing 6.97%. It has eased by 0.66% over last one week and ticked higher by 6.26% in last one month while the market capitalization of Decipher Labs Ltd has inched up 1.24% and 3.54% in the same period respectively.
Profit before tax (PBT) of Decipher Labs Ltd stood at Rs 14.07 crore in Q2 FY27, tanking 70450.00% year-on-year, and rallying 542.47% quarter-on-quarter. EBITDA came in at Rs 14 crore, tumbling by 12781.82% YoY and expanding by 520.00% sequentially.
Total expenses surged 264.68% to Rs 17.14 crore in Q2FY27 over Q2FY26. During the quarter, employee benefits expense was at Rs 2.69 crore, slipping by 2.54% YoY.
For FY26, revenue from operations tumbled 37.86% to Rs 14.05 crore, while net profit tanked by 39.37% to Rs 3.08 crore, compared to previous FY. EBITDA saw a sharp decline of 950% to Rs 3.61 crore, and PBT tumbled by 42.41% to Rs 3.68 crore compared to previous FY.
The company`s consolidated net cash flow from operating activities stood at Rs 2.08 crore in FY26, as against Rs 9.82 crore in FY25.
Decipher Labs Ltd crashed 39.42% in last one year, underperforming the benchmark BSE Sensex which has softened by 3.42% during the same period.
Decipher Labs Ltd
10 Nov 2026 12:00 AM
Decipher Labs Limited to review financial results at a board meeting November 14, 2026,
Decipher Labs Limited, formerly Combat Drugs Limited, will hold a board meeting on Saturday, November 14, 2026, to consider the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, and a limited review report for the quarter ended September 30, 2026.
Decipher Labs Ltd
29 Sep 2026 12:00 AM
Decipher Labs will restrict trading for insiders following SEBI regulations in 2026,
Decipher Labs Limited, formerly Combat Drugs Limited, will close its trading window for designated persons, their immediate relatives, and connected persons from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Decipher Labs Ltd
13 Aug 2026 12:00 AM
Decipher Labs Ltd consolidated sales down 33.06% on year in Q2FY2026, net profit saw a strong growth of 508.33%,
Decipher Labs Ltd share price slipped 1.39% to Rs 6.4 after the company`s net profit jumped 508.33% to Rs 2.19 crore, while revenue from operations nosedived 33.06% to Rs 2.41 crore in Q2FY26 over Q1FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, gaining 4.59%. It has improved by 0.97% over last one week and heading higher by 11.17% in last one month while the market capitalization of Decipher Labs Ltd has marginally improved by 4.87% and 14.78% in the same period respectively.
Profit before tax (PBT) of Decipher Labs Ltd stood at Rs 2.19 crore in Q2 FY26, tanking 35.96% year-on-year, and crashing by 976.00% quarter-on-quarter. EBITDA came in at Rs 2 crore, nosediving by 32.23% YoY and tumbling by 3850.00% sequentially.
Total expenses witnessed a sharp rise of 33.14% to Rs 4.7 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 2.76 crore, inching up 2.99% YoY.
For the TTM ended FY26, revenue from operations sank 36.98% to Rs 22.61 crore, while net profit soared by 202.38% to Rs 5.08 crore, compared to previous TTM. EBITDA saw a sharp decline of 235% to Rs 8.54 crore, and PBT soared 428.10% to Rs 6.39 crore compared to previous TTM.
The company`s consolidated net cash flow from operating activities stood at Rs 9.82 crore in FY26, as against Rs 4.85 crore in FY25.
Decipher Labs Ltd nosedived by 40.02% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.83% during the same period.
Decipher Labs Ltd
07 Aug 2026 12:00 AM
Decipher Labs to table results,
Decipher Labs will hold a meeting of the Board of Directors of the Company on 13 August 2026.
Subscribe for our
newsletter
newsletter
HSL Mobile App